Barbados vs Trinidad and Tobago: Share of adolescent girls vaccinated against human papillomavirus
Barbados
7.0%
in 2024
Trinidad and Tobago
16.0%
in 2024
Barbados rank
71st
Trinidad and Tobago rank
68th
Share of adolescent girls vaccinated against human papillomavirus over time
- Barbados
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 16.0% against 7.0% in Barbados, a difference of 9.0%.
That makes Trinidad and Tobago's figure about 2.3 times Barbados's.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Barbados ahead.
Barbados ranks 71st and Trinidad and Tobago ranks 68th of 74 countries.
Barbados has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Barbados | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.0% | 6.0% | 25.0% | Barbados |
| 2020s | 19.0% | 11.4% | 7.6% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Barbados or Trinidad and Tobago?
- Trinidad and Tobago, at 16.0% against 7.0% in Barbados as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Barbados and Trinidad and Tobago?
- 9.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Barbados and Trinidad and Tobago?
- 6 years are reported by both, from 2019 to 2024.
- How do Barbados and Trinidad and Tobago rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Barbados ranks 71st and Trinidad and Tobago ranks 68th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.